ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Clinical practice"

  • Abstract Number: 2499 • 2014 ACR/ARHP Annual Meeting

    Early Response Indicator early Predicts Clinical Response to Certolizumab in Rheumatoid Arthritis Patients

    Massimiliano Cazzato1, Laura Bazzichi2, Stefano Bombardieri3 and Camillo Giacomelli4, 1Internal Medicine, Rheumatology Unit, Pisa, Italy, 2Santa Chiara Hospital, Rheumatology, pisa, Italy, 3Rheumatology Unit, Pisa, Italy, 4Rheumatology, pisa, Italy

    Background/Purpose In the last few years the introduction of biological agents has radically changed the clinical outcome of patients with Rheumatoid Arthritis (RA). However, no…
  • Abstract Number: 824 • 2014 ACR/ARHP Annual Meeting

    Impact of Oral Glucocorticoid Therapy on Mortality in Patients with Rheumatoid Arthritis and Diabetic Mellitus

    Mohammad Movahedi and William G Dixon, Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, United Kingdom

    Background/Purpose Glucocorticoid (GC) therapy is known to increase the risk of new-onset type 2 diabetes mellitus (DM). Furthermore, GC therapy increases blood glucose in diabetic…
  • Abstract Number: 2380 • 2014 ACR/ARHP Annual Meeting

    Durability of First Biologic Is Not Influenced By Initial/Early DAS28

    Gina Rohekar1, Binu Jacob2, Janet E. Pope3 and Claire Bombardier4, 1Rheumatology, St. Joseph's Hospital, London, ON, Canada, 2University Health Network, Toronto General Research Institute, Toronto, ON, Canada, 3Medicine, Western University, London, ON, Canada, 4Rheumatology, University of Toronto, Toronto, ON, Canada

    Background/Purpose:   The Ontario Best Practices Research Initiative (OBRI) collects data on RA treatment in a real-world setting.  Patients are enrolled and prospectively followed to…
  • Abstract Number: 424 • 2014 ACR/ARHP Annual Meeting

    The Comparison Between Physical and Ultrasound Joint Examination for the Hand Joints in Patients with Rheumatoid Arthritis

    Norihide Hayashi1, Takehisa Ogura2, Ayako Hirata2, Rie Kujime3, Munetsugu Imamura1, Sayaka Takenaka3, Kennosuke Mizushina3, Sumie Nakahashi3, Hideki Ito1, Naoko Yamashita3 and Hideto Kameda1, 1Div Rheumatol, Dep Intern Med, Toho Univ, Tokyo, Japan, 2Department of Rheumatology, Toho Univ, Tokyo, Japan, 3Toho Univ, Tokyo, Japan

    Background/Purpose To establish the importance of joint examination by ultrasound (US) in daily clinical practice of patients with rheumatoid arthritis (RA), we compared the US…
  • Abstract Number: 2384 • 2014 ACR/ARHP Annual Meeting

    Factors Associated with Methotrexate Treatment Duration, Including Subcutaneous Use, in Patients with Rheumatoid Arthritis: Observations from the VA Database

    Bernard Ng, Rheumatology, U.S. Department of Veterans' Affairs- Puget Sound Healthsystem, Seattle, WA

    Background/Purpose: A previous analysis of RA patients in national administrative databases of the Department of Veterans Affairs (VA) suggested that injectable MTX was associated with…
  • Abstract Number: 430 • 2014 ACR/ARHP Annual Meeting

    Minimally Important Difference in the European Quality of Life-Five Dimensions in Patients with Rheumatoid Arthritis

    Daisuke Hoshi, Eiichi Tanaka, Eisuke Inoue, Kumi Shidara, Yoko Shimizu, Akiko Kobayashi, Naoki Sugimoto, Eri Sato, Yohei Seto, Ayako Nakajima, Shigeki Momohara, Atsuo Taniguchi and Hisashi Yamanaka, Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan

    Background/Purpose Patient-reported outcomes (PROs) have been recognized as important in evaluating disease status of rheumatoid arthritis (RA). The minimally important difference (MID) in PROs has…
  • Abstract Number: 2366 • 2014 ACR/ARHP Annual Meeting

    Effectiveness, Tolerability, and Safety of Subcutaneous Methotrexate in Early Rheumatoid Arthritis: Clinical Data from the St. Gallen Cohort

    Ruediger Mueller1, Johannes von Kempis1, Michael H Schiff2 and Sarah Haile3, 1Rheumatology, St. Gallen Hospital, CH- 9007 St.Gallen, Switzerland, 2University of Colorado, Denver, CO, 3Division of Biostatistics, Institute for Social and Preventive Medicine,, University of Zurich, Switzerland, Zurich, Switzerland

    Background/Purpose: MTX is the cornerstone of RA treatment, although limitations of systemic exposure of oral MTX may affect its efficacy. Subcutaneous (SC) MTX has greater…
  • Abstract Number: 265 • 2014 ACR/ARHP Annual Meeting

    Prevalence of Medicinal Marijuana Use Among 1000 Rheumatology Patients Attending a Community-Based Rheumatology Clinic: A Prospective Cross-Sectional Study

    Peter A. Ste-Marie1, Yoram Shir1, Emmanouil Rampakakis2, John S. Sampalis2,3, Martin Cohen4, Michael Starr5, Mark A Ware1 and Mary-Ann Fitzcharles6, 1Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, 2JSS Medical Research, Montreal, QC, Canada, 3Jewish General Hospital, McGill University, Montreal, QC, Canada, 4Rheumatology, Mcgill University Health Centre, Montreal, QC, Canada, 5Rheumatology, McGill University Health Centre, Montreal, QC, Canada, 6Rheumatology and Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada

    Background/Purpose:  With a worldwide groundswell of interest in cannabinoids as a possible treatment option for persons with rheumatic diseases, and with few pharmacologic cannabinoid options…
  • Abstract Number: 2324 • 2014 ACR/ARHP Annual Meeting

    Only 30% Rheumatologists Collect Basdai in Patients with Axial Spa in Daily Practice: The Potential Role of a Consensual Meeting to Improve It

    Hélène Che1,2, Adrien Etcheto2,3, Emmanuelle Dernis Labous4,5, Henri Nataf5, Patrick Boumier5, Philippe Breuillard5, Marianne Durandin-Truffinet5, Jacques Fechtenbaum2,5, Veronique Gaud-Listrat2,5, Bernard Giraud5, Christophe Hudry2,5, Sylvain La Batide Alanore5, Patricia Le Devic5, Patrick Le Goux5, Agnes Lebrun2,5, Emmanuel Maheu5, Bertrand Moura5, Minh Nguyen2,5, Antoinette Sacchi5, Xavier Ayral5,6, Anne Blanchais2,5, Severine Neveu2,5, Maxime Dougados2,5,7 and Anna Molto2,5,7, 1Immuno-Rhumatologie, Hopital Lapeyronie, Montpellier, France, 2Université Paris René Descartes and Hôpital Cochin, Paris, France, 3Cochin Hospital, Paris Descartes University, Paris, France, 4Rhumatologie, Ch Du Mans, Le Mans, France, 5Réseau Hôpital et Ville en Rhumatologie (RHEVER) Network, Paris, France, 6Université Paris René Descartes and Hôpital Cochin, paris, France, 7INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France., Paris, France

    Background/Purpose The current recommendations for optimal monitoring of axial spondyloarthritis (SpA) are to assess regularly disease activity. The two proposed tools comprise clinical aspects as…
  • Abstract Number: 113 • 2014 ACR/ARHP Annual Meeting

    Dermatologic Rheumatism: Our Experience with a Multidisciplinary Dermatology/Rheumatology Clinic

    Archana Sharma1, Lin A. Brown2, Dorothea Barton3 and John Mecchella4, 1Rheumatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, 2Division of Rheumatology, Dartmouth-Hitchcock Med Ctr, Lebanon, NH, 3Dermatology, Dartmouth Hitchcock Medical Center, Lebanon, NH, 4Rheumatology, Giesel school of medicine and Dartmouth Hitchcock Medical Center, Lebanon, NH

    Background/Purpose: Multidisciplinary clinics are becoming increasingly common as a way to bring together multiple specialists to care for patients with complex diseases.  While multidisciplinary clinics commonly involve…
  • Abstract Number: 1870 • 2014 ACR/ARHP Annual Meeting

    Children and Parent Satisfaction in the Pediatric Rheumatology Clinic:  Patient Orientated Quality Service Measures

    Jenny Tekano1, Lori B. Tucker2 and Audrea Chen3, 1Rheumatology, BC Children's Hospital, Vancouver, BC, Canada, 2Rheumatology, BC Children's Hospital and University of British Columbia, Vancouver, BC, Canada, 3research student, Vancouver, BC, Canada

    Background/Purpose Patient satisfaction is a multidimensional concept, and is a component of quality care. Inclusion of patient experience with care is highly relevant in improving…
  • Abstract Number: 1867 • 2014 ACR/ARHP Annual Meeting

    Mandibular Movement in Healthy Individuals from 4-17 Years of Age

    Peter Stoustrup1, Kasper Dahl Kristensen2,3, Annelise Küseler4, Thomas Klit Pedersen5,6 and Troels Herlin7, 1Section of Orthodontics, University of Aarhus, Aarhus C, Denmark, 2Section of Orthodontics, University of Aarhus, Denmark, 8000 Aarhus, Denmark, 3Specialist Oral Health Center for Western Norway, Rogaland Stavanger, Norway, 4Section of Orthodontics, Aarhus University, Aarhus, Denmark, 5Section or Orthodontics, Aarhus University, Aarhus, Denmark, 6Department of Oral and Maxillofacial Surgery, Aarhus University Hospital, Aarhus, Denmark, 7Pediatric Rheumatology Clinic, Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark

    Background/Purpose: Assessment of mandibular movement capacity is an important part of the clinical orofacial examination of patients with juvenile idiopathic arthritis (JIA). The aim of…
  • Abstract Number: 1852 • 2014 ACR/ARHP Annual Meeting

    Increased Cardiovascular Risk in Patients Recently Diagnosed with Psoriatic Arthritis: A Population-Based, Cohort Study

    Katelynn Wilton1, Floranne C. Ernste2, Cynthia S. Crowson3, Eric L. Matteson4, Hilal Maradit Kremers5 and Marta Sánchez-Menéndez6, 1Medical Scientist Training Program, Mayo Clinic Rochester, Rochester, MN, 2Division of Rheumatology, Mayo Clinic Rochester, Rochester, MN, 3Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 4Rheumatology, Mayo Clinic, Rochester, MN, 5Health Sciences Research, Mayo Clinic, Rochester, MN, 6Centro Medico de Asturias, Oviedo, Spain

    Background/Purpose: Patients diagnosed with rheumatoid arthritis and psoriatic arthritis (PsA) have an increased risk of multiple comorbidities that predispose them to cardiovascular disease (CVD). Although…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology